Latest Market Growth News

Memphasys has signed a pivotal supply agreement with Andro Diagnostics to distribute its Felix™ sperm separation system across over 200 IVF clinics in India, marking a major step in its new global go-direct commercial strategy.

Artrya Limited has secured FDA clearance for its Salix Coronary Plaque module and raised $80 million to fuel its U.S. commercial expansion, marking a pivotal step in its transition from development to revenue generation.

Bega Cheese Limited reported robust FY2025 results marked by strategic site consolidations, innovation-led growth, and a strong financial position, setting the stage for an optimistic FY2026.

Pure Hydrogen Corporation has locked in a $2.5 million loan facility to accelerate its clean energy vehicle rollout, aiming to capitalise on a growing sales pipeline in Australia and the US.

BrainChip Holdings Ltd showcased its leadership in ultra-low-power edge AI technology, emphasizing strong partnerships and a growing product portfolio targeting high-growth sectors like defense and healthcare.

Navigator Global Investments reports a 3% rise in total assets under management to USD 87 billion, driven by strong growth in Lighthouse Partners and private markets despite a challenging investment landscape.

Southern Cross Media Group reports a robust Q1 FY26 with audio revenues rising 4.7% and EBITDA more than doubling, while preparing for a pivotal merger review.

Orthocell has reported a record $3 million revenue for the September quarter, driven by strong sales of its nerve repair product Remplir™ in Australia and Singapore, with early US sales and Canadian market entry poised to accelerate growth.

First Graphene’s PureGRAPH technology underpins a new solar thermal product range launched in the UK by Senergy Innovations, targeting significant energy savings and market growth ahead of the 2027 Future Homes Standard.

Locksley Resources has completed its second tranche placement with Tribeca, significantly strengthening its cash reserves to support its U.S. mine-to-market ambitions.

The Calmer Co. has secured $700,000 in the first tranche of a $1.4 million convertible note raise, welcoming US distributor Applied Food Sciences as a strategic investor to fuel its expanding wholesale presence.

Memphasys Limited is intensifying its commercial push for Felix, an innovative automated sperm separation system for IVF, backed by a landmark Middle East partnership and a fresh capital raise to scale manufacturing and sales.